Free Trial

Baxter International (BAX) Competitors

$33.20
-0.66 (-1.95%)
(As of 05/29/2024 ET)

BAX vs. BDX, EW, DXCM, IDXX, RMD, STE, HOLX, PODD, TFX, and GMED

Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), STERIS (STE), Hologic (HOLX), Insulet (PODD), Teleflex (TFX), and Globus Medical (GMED). These companies are all part of the "health care equipment" industry.

Baxter International vs.

Becton, Dickinson and Company (NYSE:BDX) and Baxter International (NYSE:BAX) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, earnings and profitability.

In the previous week, Becton, Dickinson and Company and Becton, Dickinson and Company both had 21 articles in the media. Baxter International's average media sentiment score of 0.47 beat Becton, Dickinson and Company's score of 0.33 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
10 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Baxter International
5 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Baxter International received 140 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 66.18% of users gave Baxter International an outperform vote while only 62.29% of users gave Becton, Dickinson and Company an outperform vote.

CompanyUnderperformOutperform
Becton, Dickinson and CompanyOutperform Votes
588
62.29%
Underperform Votes
356
37.71%
Baxter InternationalOutperform Votes
728
66.18%
Underperform Votes
372
33.82%

Baxter International has lower revenue, but higher earnings than Becton, Dickinson and Company. Baxter International is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$19.37B3.36$1.48B$4.5449.54
Baxter International$14.81B1.14$2.66B$5.206.38

Becton, Dickinson and Company has a beta of 0.45, suggesting that its stock price is 55% less volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500.

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 0.3% of Becton, Dickinson and Company shares are owned by company insiders. Comparatively, 0.2% of Baxter International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Baxter International has a net margin of 17.79% compared to Baxter International's net margin of 6.76%. Becton, Dickinson and Company's return on equity of 18.47% beat Baxter International's return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company6.76% 13.90% 6.73%
Baxter International 17.79%18.47%4.91%

Becton, Dickinson and Company currently has a consensus target price of $281.40, suggesting a potential upside of 25.11%. Baxter International has a consensus target price of $45.18, suggesting a potential upside of 36.11%. Given Becton, Dickinson and Company's higher probable upside, analysts clearly believe Baxter International is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Baxter International
0 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Becton, Dickinson and Company pays an annual dividend of $3.80 per share and has a dividend yield of 1.7%. Baxter International pays an annual dividend of $1.16 per share and has a dividend yield of 3.5%. Becton, Dickinson and Company pays out 83.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Baxter International pays out 22.3% of its earnings in the form of a dividend. Becton, Dickinson and Company has raised its dividend for 52 consecutive years and Baxter International has raised its dividend for 8 consecutive years. Baxter International is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Baxter International beats Becton, Dickinson and Company on 11 of the 20 factors compared between the two stocks.

Get Baxter International News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAX vs. The Competition

MetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$17.25B$3.88B$5.04B$17.69B
Dividend Yield3.43%1.78%2.82%3.54%
P/E Ratio6.388.55124.2021.54
Price / Sales1.1469.642,490.9410.09
Price / Cash6.4647.9234.5419.27
Price / Book2.055.855.495.82
Net Income$2.66B$4.50M$105.53M$975.72M
7 Day Performance-2.40%0.40%0.60%-0.51%
1 Month Performance-17.77%0.63%2.50%2.67%
1 Year Performance-17.69%16.87%5.32%22.10%

Baxter International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BDX
Becton, Dickinson and Company
4.9767 of 5 stars
$226.85
-0.8%
$281.40
+24.0%
-6.7%$65.56B$19.37B49.9773,000Short Interest ↓
Analyst Revision
EW
Edwards Lifesciences
4.7463 of 5 stars
$87.04
-1.1%
$94.31
+8.4%
+6.2%$52.45B$6.00B37.5219,800Short Interest ↓
DXCM
DexCom
4.9558 of 5 stars
$127.38
+0.0%
$141.67
+11.2%
+10.9%$50.66B$3.62B82.189,600Analyst Forecast
Short Interest ↓
Positive News
IDXX
IDEXX Laboratories
4.3417 of 5 stars
$505.40
-2.1%
$580.38
+14.8%
+6.3%$41.74B$3.66B48.9311,000Positive News
RMD
ResMed
4.455 of 5 stars
$207.17
-2.9%
$202.80
-2.1%
-4.4%$30.44B$4.22B31.8210,140Analyst Revision
STE
STERIS
4.1489 of 5 stars
$223.39
-2.5%
$241.60
+8.2%
+11.5%$22.07B$5.14B58.4817,100Analyst Revision
HOLX
Hologic
4.7504 of 5 stars
$73.36
-0.6%
$85.60
+16.7%
-8.4%$17.12B$3.96B37.436,990Analyst Revision
PODD
Insulet
4.9021 of 5 stars
$177.82
-1.2%
$239.44
+34.7%
-36.8%$12.45B$1.70B53.883,000Insider Selling
Short Interest ↑
Positive News
TFX
Teleflex
4.6962 of 5 stars
$204.64
-0.8%
$261.75
+27.9%
-12.8%$9.64B$2.97B32.8514,500Short Interest ↑
High Trading Volume
GMED
Globus Medical
4.6926 of 5 stars
$65.48
-0.5%
$68.50
+4.6%
+23.3%$8.86B$1.90B102.315,000Analyst Forecast
Short Interest ↓

Related Companies and Tools

This page (NYSE:BAX) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners